M2 Receptor Measurements in Aging and in Alzheimer's Disease View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

1999-2005

ABSTRACT

The purpose of this study is to use brain imaging technology to study the effects of aging and Alzheimer's Disease (AD) on a specific type of brain receptor. The brain is made up of cells called neurons. The neurons communicate with one another and secrete chemicals called neurotransmitters. The neurotransmitters bind to specific sites on other neurons called receptors. Acetylcholine (ACh) is a neurotransmitter that binds to ACh receptors. In both aging and AD, the number of neurons that secrete ACh decreases and the function of some ACh receptors changes. This study will use positron emission tomography (PET) scans of the brain to study the effects of age and AD on muscarinic type 2 [M2], a type of ACh receptor. Participants in this study will be injected with a radioactive tracer (ligand [F-18] FP-TZTP) which binds to [M2] receptors. Participants will then undergo a PET scan in order for the density and function of [M2] receptors to be studied. Detailed Description The Geriatric Psychiatry Branch (GPB) of the National Institute of Mental Health (NIMH) proposes to study the effect of aging and Alzheimer's Disease (AD) on muscarinic type 2 (M2) receptor density and function using the ligand [F-18] FP-TZTP. M2 receptors are primarily autoreceptors found on acetylcholine (ACh) neurons, and are lost along with ACh neurons in aging and AD, particularly in the cerebral cortex. As we near completion of the study of the young versus the old, we would like to add a few more healthy subjects to achieve better gender balance, continue the accrual of Alzheimer's patients and expand the Protocol to include its natural scientific progression. Quantification of M2 receptors with a single FP-TZTP scan as we are currently performing with 99-M-0073 provides a measure of the number of cholinergic receptors in the brain, but not their capacity to release acetylcholine into the synapse. To test this capacity requires a second TZTP scan and the use of an agent that alters acetylcholine concentrations in the synapse. Non-human primate studies performed here (1) have found PET scans with FP-TZTP to be sensitive to changes in acetylcholine synapse concentrations, as a result of competition, in response to the adminstration of the acetylinesterase inhibitor physostigmine. We would like to use physostigmine in all groups; young, older normal, and Alzheimer's patients to infer differences in capacity to release acetylcholine. More... »

URL

https://clinicaltrials.gov/show/NCT00001917

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3120", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3053", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "The purpose of this study is to use brain imaging technology to study the effects of aging and Alzheimer's Disease (AD) on a specific type of brain receptor. The brain is made up of cells called neurons. The neurons communicate with one another and secrete chemicals called neurotransmitters. The neurotransmitters bind to specific sites on other neurons called receptors. Acetylcholine (ACh) is a neurotransmitter that binds to ACh receptors. In both aging and AD, the number of neurons that secrete ACh decreases and the function of some ACh receptors changes. This study will use positron emission tomography (PET) scans of the brain to study the effects of age and AD on muscarinic type 2 [M2], a type of ACh receptor. Participants in this study will be injected with a radioactive tracer (ligand [F-18] FP-TZTP) which binds to [M2] receptors. Participants will then undergo a PET scan in order for the density and function of [M2] receptors to be studied.\n\nDetailed Description\nThe Geriatric Psychiatry Branch (GPB) of the National Institute of Mental Health (NIMH) proposes to study the effect of aging and Alzheimer's Disease (AD) on muscarinic type 2 (M2) receptor density and function using the ligand [F-18] FP-TZTP. M2 receptors are primarily autoreceptors found on acetylcholine (ACh) neurons, and are lost along with ACh neurons in aging and AD, particularly in the cerebral cortex. As we near completion of the study of the young versus the old, we would like to add a few more healthy subjects to achieve better gender balance, continue the accrual of Alzheimer's patients and expand the Protocol to include its natural scientific progression. Quantification of M2 receptors with a single FP-TZTP scan as we are currently performing with 99-M-0073 provides a measure of the number of cholinergic receptors in the brain, but not their capacity to release acetylcholine into the synapse. To test this capacity requires a second TZTP scan and the use of an agent that alters acetylcholine concentrations in the synapse. Non-human primate studies performed here (1) have found PET scans with FP-TZTP to be sensitive to changes in acetylcholine synapse concentrations, as a result of competition, in response to the adminstration of the acetylinesterase inhibitor physostigmine. We would like to use physostigmine in all groups; young, older normal, and Alzheimer's patients to infer differences in capacity to release acetylcholine.", 
    "endDate": "2005-04-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT00001917", 
    "keywords": [
      "M2 receptor", 
      "Alzheimer Disease", 
      "brain imaging technology", 
      "aging", 
      "specific type", 
      "brain receptor", 
      "brain", 
      "neuron", 
      "neuron communicate", 
      "chemical", 
      "Neurotransmitter Agent", 
      "specific site", 
      "called receptor", 
      "acetylcholine", 
      "ACh", 
      "ACh receptor", 
      "receptor change", 
      "Positron-Emission Tomography", 
      "age", 
      "M2", 
      "radioactive tracer", 
      "ligand", 
      "F-18", 
      "FP", 
      "receptor", 
      "density", 
      "geriatric psychiatry", 
      "National Institute Mental Health", 
      "National Institute of Mental Health", 
      "receptor density", 
      "cerebral cortex", 
      "completion", 
      "healthy subject", 
      "gender balance", 
      "accrual", 
      "Alzheimer's", 
      "patient", 
      "protocol", 
      "quantification", 
      "Weight and Measure", 
      "cholinergic receptor", 
      "capacity", 
      "Synapsis", 
      "agent", 
      "non-human primate study", 
      "competition", 
      "physostigmine", 
      "difference"
    ], 
    "name": "M2 Receptor Measurements in Aging and in Alzheimer's Disease", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT00001917"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00000.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.410305.3", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.416868.5", 
        "type": "Organization"
      }
    ], 
    "startDate": "1999-04-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1007/bf00426316", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040496315", 
          "https://doi.org/10.1007/bf00426316"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00426316", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040496315", 
          "https://doi.org/10.1007/bf00426316"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1176/ajp.139.11.1421", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063473032"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1192/bjp.138.1.46", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064167518"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT00001917"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT00001917'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT00001917'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT00001917'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT00001917'


 

This table displays all metadata directly associated to this object as RDF triples.

82 TRIPLES      16 PREDICATES      68 URIs      57 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT00001917 schema:about anzsrc-for:3053
2 anzsrc-for:3120
3 schema:description The purpose of this study is to use brain imaging technology to study the effects of aging and Alzheimer's Disease (AD) on a specific type of brain receptor. The brain is made up of cells called neurons. The neurons communicate with one another and secrete chemicals called neurotransmitters. The neurotransmitters bind to specific sites on other neurons called receptors. Acetylcholine (ACh) is a neurotransmitter that binds to ACh receptors. In both aging and AD, the number of neurons that secrete ACh decreases and the function of some ACh receptors changes. This study will use positron emission tomography (PET) scans of the brain to study the effects of age and AD on muscarinic type 2 [M2], a type of ACh receptor. Participants in this study will be injected with a radioactive tracer (ligand [F-18] FP-TZTP) which binds to [M2] receptors. Participants will then undergo a PET scan in order for the density and function of [M2] receptors to be studied. Detailed Description The Geriatric Psychiatry Branch (GPB) of the National Institute of Mental Health (NIMH) proposes to study the effect of aging and Alzheimer's Disease (AD) on muscarinic type 2 (M2) receptor density and function using the ligand [F-18] FP-TZTP. M2 receptors are primarily autoreceptors found on acetylcholine (ACh) neurons, and are lost along with ACh neurons in aging and AD, particularly in the cerebral cortex. As we near completion of the study of the young versus the old, we would like to add a few more healthy subjects to achieve better gender balance, continue the accrual of Alzheimer's patients and expand the Protocol to include its natural scientific progression. Quantification of M2 receptors with a single FP-TZTP scan as we are currently performing with 99-M-0073 provides a measure of the number of cholinergic receptors in the brain, but not their capacity to release acetylcholine into the synapse. To test this capacity requires a second TZTP scan and the use of an agent that alters acetylcholine concentrations in the synapse. Non-human primate studies performed here (1) have found PET scans with FP-TZTP to be sensitive to changes in acetylcholine synapse concentrations, as a result of competition, in response to the adminstration of the acetylinesterase inhibitor physostigmine. We would like to use physostigmine in all groups; young, older normal, and Alzheimer's patients to infer differences in capacity to release acetylcholine.
4 schema:endDate 2005-04-01T00:00:00Z
5 schema:keywords ACh
6 ACh receptor
7 Alzheimer Disease
8 Alzheimer's
9 F-18
10 FP
11 M2
12 M2 receptor
13 National Institute Mental Health
14 National Institute of Mental Health
15 Neurotransmitter Agent
16 Positron-Emission Tomography
17 Synapsis
18 Weight and Measure
19 accrual
20 acetylcholine
21 age
22 agent
23 aging
24 brain
25 brain imaging technology
26 brain receptor
27 called receptor
28 capacity
29 cerebral cortex
30 chemical
31 cholinergic receptor
32 competition
33 completion
34 density
35 difference
36 gender balance
37 geriatric psychiatry
38 healthy subject
39 ligand
40 neuron
41 neuron communicate
42 non-human primate study
43 patient
44 physostigmine
45 protocol
46 quantification
47 radioactive tracer
48 receptor
49 receptor change
50 receptor density
51 specific site
52 specific type
53 schema:name M2 Receptor Measurements in Aging and in Alzheimer's Disease
54 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT00001917
55 schema:sdDatePublished 2019-03-07T15:21
56 schema:sdLicense https://scigraph.springernature.com/explorer/license/
57 schema:sdPublisher N97040e1975e54371876f334a3c055140
58 schema:sponsor https://www.grid.ac/institutes/grid.410305.3
59 https://www.grid.ac/institutes/grid.416868.5
60 schema:startDate 1999-04-01T00:00:00Z
61 schema:subjectOf sg:pub.10.1007/bf00426316
62 https://doi.org/10.1176/ajp.139.11.1421
63 https://doi.org/10.1192/bjp.138.1.46
64 schema:url https://clinicaltrials.gov/show/NCT00001917
65 sgo:license sg:explorer/license/
66 sgo:sdDataset clinical_trials
67 rdf:type schema:MedicalStudy
68 N97040e1975e54371876f334a3c055140 schema:name Springer Nature - SN SciGraph project
69 rdf:type schema:Organization
70 anzsrc-for:3053 schema:inDefinedTermSet anzsrc-for:
71 rdf:type schema:DefinedTerm
72 anzsrc-for:3120 schema:inDefinedTermSet anzsrc-for:
73 rdf:type schema:DefinedTerm
74 sg:pub.10.1007/bf00426316 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040496315
75 https://doi.org/10.1007/bf00426316
76 rdf:type schema:CreativeWork
77 https://doi.org/10.1176/ajp.139.11.1421 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063473032
78 rdf:type schema:CreativeWork
79 https://doi.org/10.1192/bjp.138.1.46 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064167518
80 rdf:type schema:CreativeWork
81 https://www.grid.ac/institutes/grid.410305.3 schema:Organization
82 https://www.grid.ac/institutes/grid.416868.5 schema:Organization
 




Preview window. Press ESC to close (or click here)


...